BowLeven PLC Moves Closer To $250m Deal

If the Etinde farm-out completes, BowLeven PLC (LON:BLVN) could look very cheap at today’s price.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

oil rigBowLeven (LSE: BLVN) announced this morning that the Cameroon government had granted approval for the firm to assign 50% of its interest in the Etinde Permit to partners Lukoil and NewAge, in a deal worth $250m to the AIM-listed firm.

On first reading this morning’s news, I assumed this meant that this deal — which was originally scheduled to be completed by 31 August 2014 — could now be completed. However, it turns out that following government approval, Cameroon’s president must now issue a signed decree to formalise the deal. As a result, the deal deadline is being extended again, from 31 October to 31 December 2014.

Patience worthwhile?

Although news of further delay is frustrating for Bowleven shareholders, the Etinde asset is thought to contain in excess of 1,500 billion cubic feet of gas, and I believe patience is worthwhile.

In my view, this deal is almost certain to complete successfully, and will be worth the wait: on completion of the deal, Bowleven will be entitled to a $40m carry on two fast-tracked Etinde appraisal wells, plus an immediate cash payment of $170m, with a further $40m cash payable if certain milestones are reached as the project develops.

Bowleven is working towards a 20-year gas sale agreement to a local fertiliser plant, and towards a joint venture LNG plant for the remainder of the Etinde gas, both of which could provide attractive long-term cash flow to fund future projects.

Other prospects

The $170m cash payment will enable Bowleven to fund its share of Etinde costs and also to focus its attention on some of its other promising exploration assets, most notably the Bomono permit, where Bowleven is currently planning to drill two exploration wells, starting in late 2014.

Bowleven also has early-stage exploration assets in Kenya and Zambia, with more in the pipeline.

Selling at a discount?

Bowleven’s current market capitalisation of £104m is roughly equal to $170m. At the time of its last financial report, Bowleven had $38m in the bank and no debt.

Assuming the Lukoil/NewAge farm-out completes by the end of the year, today’s 32p share price could be below Bowleven’s net cash per share — without attaching any value to its remaining 25% stake in Etinde and to the other assets in its portfolio.

That looks too cheap to me, and I believe that now could be a good time to buy into Bowleven.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »